See also this year's filing and all EDGAR filings for this company.
PDF Report 0001589150_2023_Regen_BioPharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001589150, Regen BioPharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 336,422 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 222,580 |
| 4 | LiabilitiesCurrent | 8,595,061 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 28,055 |
| 9 | ResearchAndDevelopmentExpense | 158,138 |
| 10 | remainder_Expenses | 388,929 |
| 11 | remainder_Revenues | 125,517 |
| 12 | remainder_NetIncome | 2,893,136 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 559,002 |
| 1 | Liabilities | 8,595,061 |
| 2 | Expenses | 575,122 |
| 3 | Revenues | 125,517 |
| 4 | StockholdersEquity | -8,036,059 |
| 5 | NetIncome | 2,443,531 |
| 6 | ComprehensiveNetIncome | 2,443,531 |
| 7 | BaseVar | 6,373,919 |
| 8 | EconomicCapitalRatio | -2.49 |
Edgar->Model Mapping
Feature Distribution
Change over Time
